Causes of Pruritus in Patients Treated With Immune Checkpoint Inhibitors for Melanomas or Skin Carcinomas

Background: Pruritus is a frequent adverse event during the use of immune checkpoint inhibitors (ICIs), with a frequency estimated to be between 11 and 47%. The underlying causes remain poorly understood. Objectives: The main goal was to search for putative causes of pruritus occurring in patients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas, Nadia, Nowak, Emmanuel, Etienne, Maxime, Legoupil, Delphine, Fouchard, Maxime, Brenaut, Emilie, Misery, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900003/
https://www.ncbi.nlm.nih.gov/pubmed/33634154
http://dx.doi.org/10.3389/fmed.2021.632683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900003/
https://www.ncbi.nlm.nih.gov/pubmed/33634154
http://dx.doi.org/10.3389/fmed.2021.632683

Ejemplares similares